Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -44.97%-8.95M | -20.74%-3.1M | -22.57%-1.75M | -152.08%-2.37M | -39.67%-1.73M | 40.60%-6.17M | -146.97%-2.57M | -1.24%-1.43M | 73.15%-939.78K | 72.08%-1.24M |
| Net income from continuing operations | 394.59%18.4M | -56.39%-4.42M | 355.87%3.32M | 2,270.47%21.58M | -84.15%-2.08M | 56.08%-6.25M | 48.17%-2.83M | 14.62%-1.3M | 51.26%-994.28K | 78.33%-1.13M |
| Operating gains losses | ---8.8M | --0 | ---5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -3.10%101.76K | -18.22%21.79K | 3.41%27.07K | -3.99%25.74K | 7.01%27.16K | 0.19%105.02K | -6.02%26.65K | 10.03%26.17K | -1.30%26.81K | -0.51%25.38K |
| Asset impairment expenditure | 487.73%734.66K | ---- | ---- | ---- | ---- | -96.87%125K | -96.73%125K | ---- | ---- | ---- |
| Remuneration paid in stock | 75.29%186.12K | -92.38%6.55K | 2,471.76%166.55K | 0.00%6.48K | -10.68%6.55K | -26.42%106.18K | -40.47%85.9K | --6.48K | --6.48K | --7.33K |
| Deferred tax | 63.85%837.44K | 17.54%250.21K | 37.81%127.17K | 126.83%202.16K | 120.73%257.9K | -73.00%511.11K | 4.50%212.87K | -62.70%92.28K | -91.12%89.13K | -73.31%116.84K |
| Other non cashItems | -16,267.01%-19.58M | --0 | --0 | ---- | ---- | ---119.64K | ---- | ---- | ---- | ---- |
| Change In working capital | -26.48%-827.84K | 532.48%307.8K | -52.83%-387.38K | -1,080.60%-801.85K | 120.46%53.6K | 71.63%-654.49K | -133.76%-71.17K | -59.19%-253.48K | 97.45%-67.92K | -186.88%-261.93K |
| -Change in receivables | -75.33%-1.06M | 136.39%108.69K | -426.13%-507.3K | -237.72%-316.37K | -196.21%-348.03K | 67.86%-606.31K | -50.51%-298.71K | 61.93%-96.42K | 90.64%-93.68K | 72.91%-117.5K |
| -Change in prepaid assets | 178.56%226.08K | 162.91%93.48K | 56.42%-63.93K | 221.75%234.37K | 42.11%-37.83K | -6,413.94%-287.79K | -203.59%-148.58K | -268.41%-146.69K | 144.81%72.84K | 9.74%-65.35K |
| -Change in payables and accrued expense | -96.20%9.1K | -71.92%105.63K | 1,874.30%183.85K | -1,428.90%-719.85K | 655.71%439.46K | 157.55%239.6K | 41.49%376.13K | -249.09%-10.36K | 96.85%-47.08K | -109.79%-79.08K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -44.97%-8.95M | -20.74%-3.1M | -22.57%-1.75M | -152.08%-2.37M | -39.67%-1.73M | 40.60%-6.17M | -146.97%-2.57M | -1.24%-1.43M | 73.15%-939.78K | 72.08%-1.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 276.90%12.16M | 1,011.06%9.02M | -86.19%165.88K | 232.38%1.85M | 70.98%1.12M | -34.86%3.23M | 79.77%811.9K | 1,106.09%1.2M | -71.44%555.73K | -73.24%656.83K |
| Net PPE purchase and sale | 29.40%4.17M | 27.81%1.04M | -86.19%165.88K | 232.38%1.85M | 70.98%1.12M | -34.86%3.23M | 79.77%811.9K | 1,106.09%1.2M | -71.44%555.73K | -73.24%656.83K |
| Net intangibles purchas and sale | --8M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---17K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 276.90%12.16M | 1,011.06%9.02M | -86.19%165.84K | 226.51%1.85M | 73.63%1.12M | -34.86%3.23M | 79.77%811.9K | 1,106.09%1.2M | -70.93%565.73K | -73.65%646.83K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 8,152.46%2.51M | -101,023.27%-7.99M | 85,901.48%6.72M | 48,883.85%3.79M | -3.29%-7.97K | -3.27%-31.23K | -3.28%-7.9K | -3.31%-7.84K | -3.31%-7.77K | -3.20%-7.72K |
| Net issuance payments of debt | 14.15%-26.81K | 65.66%-2.71K | -3.32%-8.1K | -3.32%-8.03K | -3.29%-7.97K | -3.27%-31.23K | -3.28%-7.9K | -3.31%-7.84K | -3.31%-7.77K | -3.20%-7.72K |
| Net common stock issuance | --1.75M | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | --792.43K | ---7.99M | --4.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 8,152.46%2.51M | -101,023.27%-7.99M | 85,901.48%6.72M | 48,883.85%3.79M | -3.29%-7.97K | -3.27%-31.23K | -3.28%-7.9K | -3.31%-7.84K | -3.31%-7.77K | -3.20%-7.72K |
| Net cash flow | ||||||||||
| Beginning cash position | -24.32%9.1M | 55.47%16.89M | 7.13%11.8M | -25.64%8.52M | -24.32%9.1M | -29.94%12.02M | -12.23%10.86M | -18.71%11.02M | -22.57%11.46M | -29.94%12.02M |
| Current changes in cash | 292.10%5.72M | -17.50%-2.07M | 2,311.23%5.14M | 956.45%3.27M | -2.72%-618.53K | 45.55%-2.98M | -196.11%-1.76M | 82.33%-232.53K | 75.55%-381.82K | 69.86%-602.13K |
| Effect of exchange rate changes | 4.56%58.85K | 1,496.03%60.42K | -174.30%-57.61K | 125.66%14.55K | 4.35%41.49K | -83.26%56.29K | -101.83%-4.33K | -44.28%77.53K | -117.68%-56.68K | 111.03%39.76K |
| End cash Position | 63.56%14.88M | 63.56%14.88M | 55.47%16.89M | 7.13%11.8M | -25.64%8.52M | -24.32%9.1M | -24.32%9.1M | -12.23%10.86M | -18.71%11.02M | -22.57%11.46M |
| Free cash from | -45.76%-9.7M | -26.16%-3.34M | -29.54%-1.89M | -132.48%-2.42M | -35.88%-2.05M | 39.20%-6.66M | -156.03%-2.64M | 8.88%-1.46M | 70.14%-1.04M | 68.65%-1.51M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.